Document:

Exhibit 10.1
EXECUTION COPY

                    SECOND AMENDMENT TO EMPLOYMENT AGREEMENT

     This second amendment to the Employment Agreement (as defined below), dated
as of November 8, 2004 (this  "Amendment"),  is made between  Asbury  Automotive
Group,  Inc.,  a Delaware  corporation  (the  "Company"),  and Kenneth B. Gilman
("Executive").

                                    RECITALS

     WHEREAS Asbury  Automotive  Group,  L.L.C.  and Executive  entered into the
Employment Agreement, dated as of December 3, 2001, as amended February 26, 2004
(the "Employment Agreement");

     WHEREAS, on March 19, 2002, the Company became the successor in interest of
Asbury Automotive Group, L.L.C.;

     WHEREAS  the  Company  and  Executive  have agreed to renew the term of the
Employment  Agreement  for an  additional  year through  December  31, 2005,  as
contemplated by Section 12(c) of the Employment Agreement; and

     WHEREAS the Company and Executive desire to amend the Employment  Agreement
as set forth below.

     NOW  THEREFORE,  for good  and  valuable  consideration,  the  receipt  and
sufficiency of which are hereby acknowledged, the parties hereto hereby agree as
follows:

1.   Section 3(b) of the Employment Agreement is hereby amended by adding to the
     end of the second sentence therein the following:

     ; provided,  however, that this sentence shall not be deemed breached by
     any other officer's reporting to the Board in order to comply with the
     Sarbanes-Oxley  Act of  2002 or  other  applicable  law or  regulation
    (including applicable stock exchange requirements).

2.   Section 5 of the  Employment  Agreement  is hereby  amended  to read in its
     entirety as follows:

     Commencing  in  calendar  year 2004,  during the Term,  Executive  shall be
     entitled to earn an annual bonus  pursuant to the  Company's  Key Executive
     Incentive  Compensation  Plan  (or  an  applicable  successor  plan),  on a
     calendar year basis, ("Target Bonus") of up to one times his Base Salary if
     the Company achieves  specified  objectives (the "Targets")  established by
     the Compensation  Committee (the "Compensation  Committee") of the Board of
     Directors  no later than the 90th day of each such year after  consultation
     with  the  Executive,   and  the  Compensation   Committee   certifies  the
     achievement of such Targets. Such Targets shall be substantially similar to
     those  Targets  established  for purposes of computing  annual  bonuses for
     other senior officers of the Company. If the Company's  performance exceeds
     the Targets,  Executive  shall be entitled to receive an additional  annual
     bonus of up to one times his Base  Salary  (the  "Additional  Bonus").  The
     Compensation Committee shall, after consultation with Executive,  prescribe
     a schedule  setting forth the percentage of the Additional  Bonus Executive
     shall  earn  based on the  performance  of the  Company  in  excess  of the
     Targets.  On or about  December  15 of each  year,  the  Company  shall pay
     Executive  80%  of  the  Target  Bonus  and   Additional   Bonus  that  the
     Compensation  Committee  determines in good faith is likely to be earned by
     Executive  with  respect  to  that  year  (the  "Tentative   Bonus").   The
     Compensation Committee shall certify whether the relevant performance goals
     have been  achieved  and,  based on such  certification,  shall  thereafter
     determine the actual Target Bonus and Additional  Bonus earned by Executive
     with respect to the year described in the preceding  sentence no later than
     30 days after  delivery  to the Board of  Directors  of  audited  financial
     statements  for the Company for the  relevant  calendar  year (the  "Actual
     Bonus").  If the Tentative  Bonus paid to Executive is less than the Actual
     Bonus,  the Company shall  promptly pay Executive  the  difference.  If the
     Tentative Bonus paid to Executive is more than the Actual Bonus,  Executive
     shall promptly pay the Company the amount of the overpayments,  and, to the
     extent such overpayments have not theretofore been paid by Executive to the
     Company,  the  Company  shall be  entitled  to  recover  the  amount of the
     overpayments  from  other  payments  due  Executive,   including,   without
     limitation, Executive's Base Salary.

3.   Section  6(d) is hereby  added to the  Employment  Agreement to read in its
     entirety as follows:

     Executive shall be reimbursed by the Company for medical expenses  incurred
     during the Term and covered by the Company's  group medical plan as then in
     effect to the extent such plan does not reimburse such  expenses,  provided
     such expenses  relate to  underlying  claims that are eligible for coverage
     under such plan.  Such  expenses  shall include  deductibles,  co-payments,
     co-insurance,   and   amounts   above  the  usual  and   customary   level.
     Reimbursements  shall not be provided for health expenses related to claims
     that are not deemed covered expenses by the group medical plan, even though
     they may be deductible  expenses under Section 213 of the Internal  Revenue
     Code of 1986,  except to the extent such  expenses are incurred  during the
     Term and are  currently  being  reimbursed by the Company as of November 8,
     2004.

4.   Section  6(e) is hereby  added to the  Employment  Agreement to read in its
     entirety as follows:

     Upon Executive's termination of employment from the Company,  Executive may
     elect to continue to  participate in the Company's  medical  insurance plan
     until the earliest of (i) Executive  becoming eligible for coverage under a
     similar plan of a subsequent employer; (ii) the Company's failing to obtain
     coverage for Executive under such plan with the applicable  insurer of such
     plan; provided,  however, that this clause (ii) shall not apply if the plan
     is self  insured  (and to the  extent the  Company  only  insures  the plan
     through catastrophic  stop-loss  insurance,  the plan shall be deemed to be
     self insured for purposes of this Section 6(e)); further provided, however,
     that the Company  shall use its  commercially  reasonable  best  efforts to
     obtain coverage for Executive  under such plan with the applicable  insurer
     of such plan if the Company  maintains such plan as an insured plan;  (iii)
     such  arrangement  becoming  prohibited  by  law or  regulation;  provided,
     however,   that  in  such  event,   Executive's  election  to  continue  to
     participate in the Company's  medical  insurance plan shall be limited only
     to the extent  necessary  to comply with such law or  regulation;  and (iv)
     Executive's failure to comply with the payment requirements of this Section
     6(e) (other  than an  inadvertent  failure to timely  make such  payments).
     Executive shall be responsible for the full cost of such medical  insurance
     coverage,  which  shall be  billed  at the  Company's  COBRA  rate for such
     coverage as in effect from time to time (which may change from time to time
     to reflect  changes in the cost of coverage)  and which shall be payable in
     the same  manner as the  Company  requires  for COBRA  payments  generally.
     Notwithstanding the foregoing, this Section 6(e) shall not apply (A) in the
     event  Executive  is  terminated  for Good Cause (as defined  below) or (B)
     following  Executive's  failure  at any  time to  elect  to  continue  such
     participation in the Company's medical insurance plan.

5.   Section 12(a) of the  Employment  Agreement is hereby  amended by adding to
     the end of such section the following:

     Notwithstanding  the  foregoing  provisions of this Section  12(a),  in all
     events (including without limitation a termination of employment  described
     in Section  12(c)) the provisions of Section 6(e) shall apply in accordance
     with the terms thereof.

6.   Section  12(d)(ii)(E)  of the  Employment  Agreement  is hereby  amended by
     adding to the end of such clause the following:

     ; provided,  however,  that this clause (E) shall not be deemed breached by
     any  other  officer  reporting  to the  Board in order to  comply  with the
     Sarbanes-Oxley Act of 2002 or other applicable law or regulation (including
     applicable stock exchange requirements);

7.   Section 13(d) of the Employment  Agreement is hereby amended to read in its
     entirety as follows:

     "Change in Control" shall have the meaning  ascribed to the term "Change of
     Control"  in the  Company's  2002  Equity  Incentive  Plan as in  effect on
     November 8, 2004 (without regard to any amendment subsequent to such date).

8.   The last  sentence  of Section  15 of the  Employment  Agreement  is hereby
     amended to read in its entirety as follows:

     Notwithstanding  the  foregoing,  Sections  10,  11,  14  and  17  and,  if
     Executive's  employment  terminates in a manner giving rise to a payment or
     benefit under Section 12, Section 12 shall survive the  termination of this
     Agreement.

9.   Except as specifically  amended  hereby,  the other terms and conditions of
     the Employment Agreement shall remain in full force and effect.

10.  This  Amendment may be executed in one or more  counterparts,  all of which
     shall be considered one and the same agreement.

11.  This Amendment  shall be deemed to be made in, and in all respects shall be
     interpreted,  construed and governed by and in accordance with, the laws of
     the State of New York, without regard to the conflicts of law principles of
     such State.

     IN WITNESS  WHEREOF,  the parties  hereto have caused this  Amendment to be
duly executed as of the day and year first written above.

                             ASBURY AUTOMOTIVE GROUP, INC.

                             By: /s/ Ian Snow
                                 ----------------------------------------------
                                 Name:  Ian Snow
                                 Title: Chairman of the Compensation Committee

                                 /s/ Kenneth B. Gilman
                                 ----------------------------------------------
                                 Kenneth B. Gilmanexv10w1

Table of Contents

Exhibit 10.1

AMENDMENT NO. 2

Dated as of October 21, 2004

to

THIRD AMENDED AND RESTATED

TRANSFER AND ADMINISTRATION AGREEMENT

Dated as of October 23, 2003

     THIS AMENDMENT NO. 2 (this “Amendment”) dated as of October 21, 2004 is
entered into by and among (i) NMC FUNDING CORPORATION, a Delaware corporation
(the “Transferor”), (ii) NATIONAL MEDICAL CARE, INC., a Delaware corporation,
as collection agent (the “Collection Agent”), (iii) the “Conduit Investors,”
“Bank Investors” and “Administrative Agents” identified on the signature pages
hereto and (iv) WESTLB AG, NEW YORK BRANCH, as agent (the “Agent”).

PRELIMINARY STATEMENTS

               A. The Transferor, the Collection Agent, the Conduit Investors, the Bank
Investors, the Administrative Agents and the Agent are parties to that certain
Third Amended and Restated Transfer and Administration Agreement dated as of
October 23, 2003 (as amended or otherwise modified prior to the date hereof,
the “TAA”). Capitalized terms used herein and not otherwise defined shall have
the meanings ascribed to them in the TAA.

               B. The parties hereto have agreed to amend the TAA on the terms and
conditions hereinafter set forth and to provide for the removal of Société
Générale (“SG”) and Asset One Securitization, LLC (“Asset One”) as parties to
the TAA.

               NOW, THEREFORE, in consideration of the premises set forth above, and
other good and valuable consideration the receipt and sufficiency of which is
hereby acknowledged, the parties hereto agree as follows:

               SECTION 1. Amendments to TAA. Effective as of the Effective Date (as
defined below), the TAA is amended as follows:

	 	 	     1.1  The definition of “Commitment Termination Date” in Section 1.1
of the TAA is amended to change the date set forth therein from “October
21, 2004” to “October 20, 2005.”
	 
	 	 	     1.2  The definition of “FMCAG Bank Revolver” in Section 1.1 of the
TAA is amended to read as follows:

1

TABLE OF CONTENTS

									
	SIGNATURES
	SIGNATURES
	SIGNATURES
	SIGNATURES
	SIGNATURES
	SIGNATURES

Table of Contents

	 	 	     “FMCAG Bank Revolver” means the Amended and Restated Credit
Agreement dated as of February 21, 2003 among FMCAG, FMCH and FMC FINANCE
II S.à.r.l., as borrowers, the guarantors party thereto, the lenders
party thereto, and Bank of America, N.A., as Administrative Agent, as
amended, restated, supplemented or otherwise modified from time to time.

	 	 	     1.3  The definition of “Termination Date” in Section 1.1 of the TAA
is amended to change the date set forth in clause (v) thereof from
“October 21, 2004” to “October 20, 2005.”
	 
	 	 	     1.4  Section 10.3 of the TAA and Schedule I to the TAA are each
hereby amended to delete the notice addresses for SG and Asset One.
	 
	 	 	     1.5  Schedule II to the TAA is amended in its entirety to read as set
forth on the amended Schedule II attached hereto.
	 
	 	 	     1.6  Exhibit Q to the TAA is amended as follows:

	 	 	          (a)  the name “FMC Dialysis Services — Oregon, LLC” is replaced with
the name “Fresenius Medical Care Dialysis Services — Oregon, LLC”;
	 
	 	 	          (b)  the name “FMC Dialysis Services Colorado, LLC” is replaced with
the name “Fresenius Medical Care Dialysis Services Colorado, LLC”;
	 
	 	 	          (c)  the name “Bio-Medical Applications of New York, Inc.” is
replaced with the name “FMS New York, Inc.”; and
	 
	 	 	          (d)  the following entities are deleted from the list of Transferring
Affiliates set forth therein:

	 	 	               (i)    Bio-Medical Applications of Essex, Inc.;
	 
	 	 	               (ii)   Fresenius USA of Puerto Rico, Inc.;
	 
	 	 	               (iii)  Home Intensive Care, Inc.;
	 
	 	 	               (iv)  Prime Medical, Inc.; and
	 
	 	 	               (v)   Renal Scientific Services, Inc.

     SECTION 2. Removal of SG and Asset One.

	 	 	     2.1  SG hereby confirms that the Aggregate Unpaids owing to SG (in
its capacity as a Bank Investor and Administrative Agent) and Asset One,
if paid no later than 2:00 p.m. New York time on October 21, 2004 (the
“Payout Date”) in same day funds, will be $16,469,096.94 (the “Payout
Amount”). The Payout Amount includes, without limitation, (i) the
aggregate outstanding Net Investment held by SG and Asset One, (ii) all
accrued and unpaid Discount owing to SG and Asset One and (ii) all fees,
expenses and other amounts payable to SG and Asset One under the
Transaction Documents. Each of the parties hereto hereby acknowledges
and agrees that upon receipt by SG of the Payout Amount on the Payout
Date as described above, SG and Asset One will cease to be parties to the
TAA and will have no further rights, obligations or

2

Table of Contents

	 	 	liabilities thereunder; provided, however, that (i) the rights and
remedies of SG and Asset One with respect to any representation and
warranty made or deemed to be made by the Transferor pursuant to the TAA,
(ii) the rights of SG and Asset One under the indemnification and payment
provisions of Article VIII of the TAA, and (iii) the agreement of SG and
Asset One set forth in Section 10.9 of the TAA, shall be continuing and
shall survive payment of the Payout Amount and the removal of SG and
Asset One as parties to the TAA. The Payout Amount shall be payable in
immediately available funds on the Payout Date in accordance with such
wiring instructions as SG may furnish to the Transferor.

	 	 	     2.2  The parties hereto acknowledge that an adjustment to the Net
Investment held by the respective Related Groups is required to be made
on the Effective Date in order to ensure that the Net Investment held by
the Investors in each Related Group is proportional to their respective
Related Group Limits (as determined after giving effect to this
Amendment). Accordingly, on the Effective Date, the Transferor shall
request such Incremental Transfers, and make such repayments, in each
case a non-pro rata basis among the Related Groups, such that by the
close of business on the Effective Date the Net Investment held by the
Investors in the respective Related Groups shall be proportional to their
respective Related Group Limits.

          SECTION 3. Consent to Amendment of Receivables Purchase Agreement and
Amendment of the Transferring Affiliates Letter. Each of the parties hereto
hereby acknowledges and consents to the execution and delivery of (i) the
amendment to the Receivables Purchase Agreement in the form attached as Exhibit
A, to be entered into by and between the Transferor and the Seller as of
October 21, 2004, and (ii) the amendment to the Transferring Affiliate Letter
in the form attached as Exhibit B, to be entered into by and between the Seller
and the Transferring Affiliates as of October 21, 2004.

          SECTION 4. Conditions Precedent. This Amendment shall become effective
and be deemed effective as of the date hereof (the “Effective Date”) subject to
the satisfaction of the following conditions:

	 	 	          (a)  the Agent shall have received counterparts of this Amendment
duly executed by the Transferor, the Collection Agent, the Conduit
Investors, the Bank Investors, the Administrative Agents and the Agent;
	 
	 	 	          (b)  to the extent requested by any Conduit Investor, such Conduit
Investor shall have received confirmation from each applicable Rating
Agency that the execution and delivery of this Amendment will not result
in the reduction or withdrawal of the then current ratings of its
Commercial Paper; and
	 
	 	 	          (c)  the Agent shall have received a reaffirmation of the Parent
Agreement in substantially the form attached hereto as Exhibit C.

          SECTION 5. Covenants, Representations and Warranties of the Transferor
and the Collection Agent.

3

Table of Contents

               5.1 Upon the effectiveness of this Amendment, each of the Transferor and
the Collection Agent hereby reaffirms all covenants, representations and
warranties made by it in the TAA and agrees that all such covenants,
representations and warranties shall be deemed to have been remade as of the
effective date of this Amendment.

               5.2 Each of the Transferor and the Collection Agent hereby represents and
warrants that (i) this Amendment constitutes the legal, valid and binding
obligation of such party, enforceable against it in accordance with its terms
and (ii) upon the effectiveness of this Amendment, no Termination Event or
Potential Termination Event shall exist under the TAA.

          SECTION 6. Reference to and Effect on the TAA.

               6.1 Upon the effectiveness of this Amendment, each reference in the TAA to
“this Agreement,” “hereunder,” “hereof,” “herein,” “hereby” or words of like
import shall mean and be a reference to the TAA as amended hereby, and each
reference to the TAA in any other document, instrument and agreement executed
and/or delivered in connection with the TAA shall mean and be a reference to
the TAA as amended hereby.

               6.2 Except as specifically amended hereby, the TAA and all other
documents, instruments and agreements executed and/or delivered in connection
therewith shall remain in full force and effect and are hereby ratified and
confirmed.

               6.3 The execution, delivery and effectiveness of this Amendment shall not
operate as a waiver of any right, power or remedy of any Investor, any
Administrative Agent or the Agent under the TAA or any other document,
instrument, or agreement executed in connection therewith, nor constitute a
waiver of any provision contained therein.

          SECTION 7. Governing Law. THIS AMENDMENT SHALL BE GOVERNED AND CONSTRUED
IN ACCORDANCE WITH THE INTERNAL LAWS (AS OPPOSED TO THE CONFLICT OF LAW
PROVISIONS) AND DECISIONS OF THE STATE OF NEW YORK.

          SECTION 8. Execution in Counterparts. This Amendment may be executed in
any number of counterparts and by different parties hereto in separate
counterparts, each of which when so executed and delivered shall be deemed to
be an original and all of which taken together shall constitute but one and the
same instrument. Delivery of an executed counterpart of this Amendment by
facsimile shall be equally as effective as delivery of an original executed
counterpart of this Amendment. Any party delivering an executed counterpart of
this Amendment by facsimile shall also deliver an original executed counterpart
of this Amendment but the failure to deliver an original executed counterpart
shall not affect the validity, enforceability and binding effect of this
Amendment.

          SECTION 9. Headings. Section headings in this Amendment are included
herein for convenience of reference only and shall not constitute a part of
this Amendment for any other purpose.

4

Table of Contents

     IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
executed by their respective officers thereunto duly authorized as of the date
first written above.

	 	 	 	 	 
	 	NMC FUNDING CORPORATION,

as Transferor

 	 
	 	By:  	/s/ Mark Fawcett
 	 
	 	 	Name:  	Mark Fawcett 	 
	 	 	Title:  	Treasurer 	 
	 

	 	 	 	 	 
	 	NATIONAL MEDICAL CARE, INC., as

Collection Agent

 	 
	 	By:  	/s/ Mark Fawcett
 	 
	 	 	Name:  	Mark Fawcett 	 
	 	 	Title:  	Treasurer 	 
	 

Signature Page

Amendment No. 2 to Third Amended and Restated

Transfer and Administration Agreement

 

Table of Contents

	 	 	 	 	 
	 	PARADIGM FUNDING LLC,

as a Conduit Investor

 	 
	 	By:  	/s/ Douglas K. Johnson
 	 
	 	 	Name:  	Douglas K. Johnson 	 
	 	 	Title:  	President 	 
	 

	 	 	 	 	 
	 	WESTLB AG, NEW YORK BRANCH, as Agent, an

Administrative Agent and as a Bank Investor

 	 
	 	By:  	/s/ Matthew F. Tallo
 	 
	 	 	Name:  	Matthew F. Tallo 	 
	 	 	Title:  	Director 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	                                    /s/ Anne Lacombe
 	 
	 	 	Name:  	Anne Lacombe 	 
	 	 	Title:  	Director 	 
	 

Signature Page

Amendment No. 2 to Third Amended and Restated

Transfer and Administration Agreement

 

Table of Contents

	 	 	 	 	 
	 	GIRO MULTI-FUNDING CORPORATION,

as a Conduit Investor

 	 
	 	By:  	/s/ Matthew Dorr
 	 
	 	 	Name:  	Matthew Dorr 	 
	 	 	Title:  	Vice President 	 
	 

	 	 	 	 	 
	 	BAYERISCHE LANDESBANK, NEW YORK BRANCH,

as an Administrative Agent

 	 
	 	By:  	/s/ Alexander Kohnert
 	 
	 	 	Name:  	Alexander Kohnert 	 
	 	 	Title:  	Senior Vice President 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Lori-Ann Wynter
 	 
	 	 	Name:  	Lori-Ann Wynter 	 
	 	 	Title:  	Vice President 	 
	 

	 	 	 	 	 
	 	BAYERISCHE LANDESBANK, CAYMAN ISLANDS

BRANCH, as a Bank Investor

 	 
	 	By:  	/s/ Norman McClave
 	 
	 	 	Name:  	Norman McClave III 	 
	 	 	Title:  	First Vice President 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Lori-Ann Wynter
 	 
	 	 	Name:  	Lori-Ann Wynter 	 
	 	 	Title:  	Vice President 	 
	 

Signature Page

Amendment No. 2 to Third Amended and Restated

Transfer and Administration Agreement

 

Table of Contents

	 	 	 	 	 
	 	ASSET ONE SECURITIZATION, LLC,

as a Conduit Investor

 	 
	 	By:  	/s/ Douglas K. Johnson
 	 
	 	 	Name:  	Douglas K. Johnson 	 
	 	 	Title:  	President 	 
	 

	 	 	 	 	 
	 	SOCIÉTÉ GÉNÉRALE, as an Administrative

Agent and as a Bank Investor

 	 
	 	By:  	/s/ Sharyanne McSwain
 	 
	 	 	Name:  	Sharyanne McSwain 	 
	 	 	Title:  	Director 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Suzanne M. Tayler
 	 
	 	 	Name:  	Suzanne M. Tayler 	 
	 	 	Title:  	Vice President 	 
	 

Signature Page

Amendment No. 2 to Third Amended and Restated

Transfer and Administration Agreement

 

Table of Contents

	 	 	 	 	 
	 	LIBERTY STREET FUNDING CORP.,

as a Conduit Investor

 	 
	 	By:  	/s/ Bernard J. Angelo
 	 
	 	 	Name:  	Bernard J. Angelo 	 
	 	 	Title:  	Vice President 	 
	 

	 	 	 	 	 
	 	THE BANK OF NOVA SCOTIA, as an

Administrative Agent and as a Bank Investor

 	 
	 	By:  	/s/ Michael Eden
 	 
	 	 	Name:  	Michael Eden 	 
	 	 	Title:  	Director 	 
	 

Signature Page

Amendment No. 2 to Third Amended and Restated

Transfer and Administration Agreement

 

Table of Contents

	 	 	 	 	 
	 	LANDESBANK HESSEN-THUERINGEN GIROZENTRALE, as a Bank Investor

 	 
	 	By:  	/s/ Jens Döring
 	 
	 	 	Name:  	Jens Döring 	 
	 	 	Title:  	Assistant Vice President 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Pia Horlebein
 	 
	 	 	Name:  	Pia Horlebein 	 
	 	 	Title:  	Associate 	 
	 

Signature Page

Amendment No. 2 to Third Amended and Restated

Transfer and Administration Agreement

 

Table of Contents

AMENDED SCHEDULE II

to

THIRD AMENDED AND RESTATED

TRANSFER AND ADMINISTRATION AGREEMENT

COMMITMENTS OF BANK INVESTORS

	 	 	 	 	 
	Bank Investor
	 	Commitment

	WestLB AG, New York Branch
	 	$	145,000,000	 
	Bayerische Landesbank, Cayman Islands Branch
	 	$	140,000,000	 
	Scotiabank
	 	$	120,000,000	 
	Landesbank Hessen — Thueringen Girozentrale
	 	$	55,000,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]